Key statistics
As of last trade Twist Bioscience Corp (0ME:BER) traded at 38.72, -30.16% below its 52-week high of 55.44, set on Jul 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.36 |
---|---|
High | 39.03 |
Low | 38.31 |
Bid | 38.37 |
Offer | 38.96 |
Previous close | 38.60 |
Average volume | 13.44 |
---|---|
Shares outstanding | 58.59m |
Free float | 57.58m |
P/E (TTM) | -- |
Market cap | 2.47bn USD |
EPS (TTM) | -3.81 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 16:42 BST.
More ▼
Press releases
- Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
- Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
- Twist Bioscience to Present at Baird Global Healthcare Conference 2024
- Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
- Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
- Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
- Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
More ▼